Ibrutinib modulates the immunosuppressive CLL microenvironment through STAT3-mediated suppression of regulatory B-cell function and inhibition of the PD-1/PD-L1 pathway

Details 詳細情報について

• CRID

  1360574093471147776

• DOI

  10.1038/leu.2017.304

• ISSN

  14765551

  08876924

• Web Site

  http://www.nature.com/articles/leu2017304.pdf

  http://www.nature.com/articles/leu2017304

  http://www.nature.com/doifinder/10.1038/leu.2017.304

• Data Source

  • Crossref